[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355714-105":59,"doc-detail-355714-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","decoding-the-sphingolipid-landscape-of-clear-cell-renal-cell-carcinoma-a-single-cell-guided-prognostic-model-built-with-101-machine-learning","Decoding the Sphingolipid Landscape of Clear Cell Renal Cell Carcinoma - A Single-Cell-Guided Prognostic Model Built With 101 Machine Learning","","Clear cell renal cell carcinoma (ccRCC) shows marked heterogeneity in progression, metastasis, and treatment response, and cell-state-specific mechanisms of sphingolipid metabolism in the microenvironment remain unclear. This study integrates public multi-cohort datasets, combining single-cell RNA-seq with bulk transcriptomic and clinical data, and uses nonnegative matrix factorization to define sphingolipid metabolism–related metagenes. A prognostic model is built by evaluating 101 machine-learning combinations and validated in independent cohorts with immune, pathway, drug sensitivity, PPI, and mutation analyses. A 12-gene signature outperforms conventional variables and links risk to immune features and therapeutic vulnerabilities.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/decoding-the-sphingolipid-landscape-of-clear-cell-renal-cell-carcinoma-a-single-cell-guided-prognostic-model-built-with-101-machine-learning/355714/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/decoding-the-sphingolipid-landscape-of-clear-cell-renal-cell-carcinoma-a-single-cell-guided-prognostic-model-built-with-101-machine-learning/355714.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study?","Question",{"text":112,"@type":113},"To decode how sphingolipid metabolism shapes cell-state heterogeneity in ccRCC and to build a single-cell-guided prognostic model for risk stratification and therapeutic prioritization.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data sources and methods are used?",{"text":117,"@type":113},"The study integrates single-cell RNA-seq data from GEO and bulk transcriptomic/clinical data from Xena, ArrayExpress, and ICGC, and applies nonnegative matrix factorization to resolve cellular heterogeneity.",{"name":119,"@type":110,"acceptedAnswer":120},"How is the prognostic signature constructed and validated?",{"text":121,"@type":113},"A prognostic model is developed by screening 101 machine-learning combinations and finalizing a 12-gene signature using the Lasso+SuperPC model, then validating performance in independent cohorts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355714,1790243988,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Human Mutation  \n SPECIAL ISSUE  Variant-to-Biomarker: Multi-omics Integration for Interpreting Human Genetic Variation and Clinical Translation  \nRESEARCH ARTICLE  OPEN ACCESS   \nDecoding the Sphingolipid Landscape of Clear Cell Renal Cell Carcinoma: A Single-Cell-Guided Prognostic Model Built With 101 Machine Learning  \nJinbang Huang1 | Shunsheng Wang2 | Yaojun Zhou2 | Hui Zhang1 | Yanyuan Zhang2 | Shi Huang2 | Haiwei Su1 | Hongling Zhu2 | Yuhan Lin2 | Gang Deng1  \n1Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China | 2School of Clinical Medicine, Southwest Medical University, Luzhou, China  \nCorrespondence: Gang Deng ([dengg5@mail.sysu.edu.cn](dengg5@mail.sysu.edu.cn))  \nReceived: 20 January 2026 | Revised: 16 April 2026 | Accepted: 29 April 2026  \nGuest Editor: Shaoqiu Chen  \nKeywords: clear cell renal cell carcinoma | immunotherapy | machine learning | nonnegative matrix  \nfactorization (NMF) | prognosis prediction | prognostic model | single-cell analysis | sphingolipid metabolism | sphingolipid metabolism–related genes | tumor microenvironment  \nABSTRACT  \nBackground: Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of kidney cancer and shows marked heterogeneity in progression, metastasis, and therapeutic response. Sphingolipid metabolism has emerged as an important regulator of tumor progression and the tumor microenvironment, but its cell-state-specific role in ccRCC remains unclear. Methods: Public datasets from multiple cohorts were integrated, including single-cell RNA sequencing data from GEO and bulk transcriptomic and clinical data from Xena, ArrayExpress, and ICGC. Nonnegative matrix factorization was used to resolve cellular heterogeneity and identify sphingolipid metabolism–related characteristic genes across distinct cell subsets. A prognostic model was constructed by screening 101 machine learning combinations and validated in independent cohorts. Additional analyses included immune characterization, pathway enrichment, drug sensitivity prediction, protein–protein interaction network analysis, and mutation profiling.  \nResults: Single-cell analysis identified 23 cell clusters representing nine major cell types in ccRCC and further resolved multiple sphingolipid metabolism–related metagene-defined subclusters within immune and stromal compartments. Based on these features, 101 machine learning combinations were evaluated, and a final 12-gene prognostic signature was established using the Lasso+SuperPC model. The model showed stable prognostic performance across independent cohorts and outperformed conventional clinical variables. It was also associated with distinct immune features, predicted therapeutic vulnerabilities, and mutation-related genomic characteristics.  \nConclusion: This study provides a single-cell-guided framework for understanding sphingolipid metabolism–related heterogeneity in the ccRCC microenvironment and establishes a 12-gene prognostic signature with potential value for risk stratification and therapeutic prioritization.  \n1 | Introduction  \nClear cell renal cell carcinoma (ccRCC), constituting approximately 80% of renal malignancies, stands as one of the most  \nprevalent kidney cancers [1, 2] . As the second leading malignancy within the urinary system, its incidence has been escalating annually, presenting a formidable threat to patient survival due to its high recurrence and mortality rates and imposing  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nCopyright © 2026 Jinbang Huang et al. Human Mutation published by John Wiley & Sons Ltd.  \nHuman Mutation, 2026; 2026:3249360 1 of 27  \n[https://doi.org/10.1155/humu/3249360](https://doi.org/10.1155/humu/3249360)  \nsubstantial economic burdens on healthcare systems [3–5] . Despite advances in sur","cbCaifjUXjuEtSxu","https://ap.wps.com/l/cbCaifjUXjuEtSxu","pdf",5067502,27,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Methods (Datasets and Analytical Pipeline)\n# Results (Cell Clusters, Prognostic Signature, Validation)\n# Additional Analyses (Immunity, Pathways, Drug Sensitivity, Networks, Mutations)\n# Conclusion","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To decode how sphingolipid metabolism shapes cell-state heterogeneity in ccRCC and to build a single-cell-guided prognostic model for risk stratification and therapeutic prioritization.\"},{\"question\":\"Which data sources and methods are used?\",\"answer\":\"The study integrates single-cell RNA-seq data from GEO and bulk transcriptomic/clinical data from Xena, ArrayExpress, and ICGC, and applies nonnegative matrix factorization to resolve cellular heterogeneity.\"},{\"question\":\"How is the prognostic signature constructed and validated?\",\"answer\":\"A prognostic model is developed by screening 101 machine-learning combinations and finalizing a 12-gene signature using the Lasso+SuperPC model, then validating performance in independent cohorts.\"}]","Decoding the Sphingolipid Landscape of Clear Cell Renal Cell Carcinoma - A Single-Cell-Guided Prognostic Model Built With 101 Machine Learning | PDF",1790120616,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab441deb12eb6627c68b5e6e9f79d6e8.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7f5c1511608a0f0168e10ac6115049b.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b513f9e2a0dcc695f7a9724c345ef711.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/310063f91e0dd67c783a28ee5acb08e1.webp",980,1287]